Chemosensitivity and endocrine sensitivity predicted by combining the 80-gene signature and 70-gene signature in the prospective Neoadjuvant Breast Registry Europe – Symphony Trial (NBREaST II). (April 2018) - Göker, E.; De Roos, M.; Hendriks, M.; Van Tilburg, M.; Dreezen, C.; Stork-Sloots, L.; Van Egmond, A.; Neijenhuis, S.; Generali, D.